Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator

被引：9

作者：

Daubert, J. Claude ^{[1
]}

Leclercq, Christophe ^{[1
]}

Mabo, Philippe ^{[1
]}

机构：

[1] Hop Pontchaillou CHU, Dept Cardiol & Vasc Dis, F-35033 Rennes, France

来源：

EUROPACE | 2009年 / 11卷

关键词：

Cardiac resynchronisation therapy; Implantable cardioverter defibrillator (ICD); Biventricular ICD; Heart failure; VENTRICULAR SYSTOLIC DYSFUNCTION; CHRONIC HEART-FAILURE; COST-EFFECTIVENESS; MEDICAL THERAPY; TRIAL; GUIDELINES; CARE; MORTALITY; DEVICES; DEATH;

D O I：

10.1093/europace/eup305

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Device therapy for heart failure has a spectacular development during the last 10 years. Patients with chronic heart failure might benefit from electrical therapy with a view to: (i) resynchronize the failing and dyssynchronized heart and improve its mechanical performance or (ii) prevent the risk of sudden death by automatic defibrillation. These two therapies can be applied together with a combined device, the biventricular implantable cardioverter-defibrillator (CRT-D). Today, the proportion of CRT-D devices among all CRT devices implanted around the world is more than 75% and more than 85% in the USA. This review article will try to answer some important questions for clinical practice: is the growing use of CRT-D devices supported by clinical evidence? Is the risk-benefit profile of CRT-D favourable in particular in mildly symptomatic patients?

引用

页码：87 / 92

页数：6

共 34 条

[1]

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure [J].

Abraham, WT ;

Young, JB ;

León, AR ;

Adler, S ;

Bank, AJ ;

Hall, SA ;

Lieberman, R ;

Liem, LB ;

O'Connell, JB ;

Schroeder, JS ;

Wheelan, KR .

CIRCULATION, 2004, 110 (18) :2864-2868

[2]

Cardiac resynchronization in chronic heart failure [J].

Abraham, WT ;

Fisher, WG ;

Smith, AL ;

Delurgio, DB ;

Leon, AR ;

Loh, E ;

Kocovic, DZ ;

Packer, M ;

Clavell, AL ;

Hayes, DL ;

Ellestad, M ;

Messenger, J ;

Trupp, RJ ;

Underwood, J ;

Pickering, F ;

Truex, C ;

McAtee, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) :1845-1853

[3]

Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay [J].

Auricchio, A ;

Stellbrink, C ;

Sack, S ;

Block, M ;

Vogt, J ;

Bakker, P ;

Huth, C ;

Schöndube, F ;

Wolfhard, U ;

Böcker, D ;

Krahnefeld, O ;

Kirkels, H .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) :2026-2033

[4]

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [J].

Bardy, GH ;

Lee, KL ;

Mark, DB ;

Poole, JE ;

Packer, DL ;

Boineau, R ;

Domanski, M ;

Troutman, C ;

Anderson, J ;

Johnson, G ;

McNulty, SE ;

Clapp-Channing, N ;

Davidson-Ray, LD ;

Fraulo, ES ;

Fishbein, DP ;

Luceri, RM ;

Ip, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :225-237

[5]

Cardiac resynchronization and death from progressive heart failure - A meta-analysis of randomized controlled trials [J].

Bradley, DJ ;

Bradley, EA ;

Baughman, KL ;

Berger, RD ;

Calkins, H ;

Goodman, SN ;

Kass, DA ;

Powe, NR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (06) :730-740

[6]

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].

Bristow, MR ;

Saxon, LA ;

Boehmer, J ;

Krueger, S ;

Kass, DA ;

De Marco, T ;

Carson, P ;

DiCarlo, L ;

DeMets, D ;

White, BG ;

DeVries, DW ;

Feldman, AM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150

[7]

BRISTOW MR, 2005, CIRCULATION, V112, P673

[8]

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. [J].

Cazeau, S ;

Leclercq, C ;

Lavergne, T ;

Walker, S ;

Varma, C ;

Linde, C ;

Garrigue, S ;

Kappenberger, L ;

Haywood, GA ;

Santini, M ;

Bailleul, C ;

Daubert, JC .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) :873-880

[9]

The effect of cardiac resynchronization on morbidity and mortality in heart failure [J].

Cleland, JGF ;

Daubert, J ;

Erdmann, E ;

Freemantle, N ;

Gras, D ;

Kappenberger, L ;

Tavazzi, L ;

Cleland, JGF ;

Daubert, JC ;

Erdmann, E ;

Gras, D ;

Kappenberger, L ;

Klein, W ;

Tavazzi, L ;

Poole-Wilson, PA ;

Rydén, L ;

Wedel, H ;

Wellens, HJJ ;

Uretsky, B ;

Thygesen, K ;

Böcker, D ;

Marijianowski, MMH ;

Freemantle, N ;

Calvert, MJ ;

Christ, G ;

Fruhwald, F ;

Hofmann, R ;

Krypta, A ;

Leisch, F ;

Pacher, R ;

Rauscha, F ;

Tavernier, R ;

Thomsen, PEB ;

Boesgaard, S ;

Eiskjær, H ;

Esperen, GT ;

Haarbo, J ;

Hagemann, A ;

Korup, E ;

Moller, M ;

Mortensen, P ;

Sogaard, P ;

Vesterlund, T ;

Huikuri, H ;

Niemelä, KI ;

Toivonen, L ;

Bauer, F ;

Cohen-Solal, A ;

Crocq, C ;

Djiane, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1539-1549

[10]

The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].

Cleland, JGF ;

Swedberg, K ;

Follath, F ;

Komajda, M ;

Cohen-Solal, A ;

Aguilar, JC ;

Dietz, R ;

Gavazzi, A ;

Hobbs, R ;

Korewicki, J ;

Madeira, HC ;

Moiseyev, VS ;

Preda, I ;

van Gilst, WH ;

Widimsky, J ;

Freemantle, N ;

Eastaugh, J ;

Mason, J .

EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463

← 1 2 3 4 →